BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23093228)

  • 1. Calprotectin: a novel biomarker for the diagnosis of pleural effusion.
    Sánchez-Otero N; Blanco-Prieto S; Páez de la Cadena M; Vázquez-Iglesias L; Fernández-Villar A; Botana-Rial MI; Rodríguez-Berrocal FJ
    Br J Cancer; 2012 Nov; 107(11):1876-82. PubMed ID: 23093228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Combination of Calprotectin and CXCL12 for Predicting Malignancy in Patients with Exudative Pleural Effusion.
    Luo J; Wang M; Li C; Liang B; Liu D; Shi C; Jiang F; Wang T; Li P; Liang Z
    Medicine (Baltimore); 2015 Nov; 94(47):e2105. PubMed ID: 26632726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial.
    Botana-Rial M; Vázquez-Iglesias L; Casado-Rey P; Cadena MP; Andrade-Olivié MA; Abal-Arca J; García-Nimo L; Ferreiro-Fernández L; Valdés-Cuadrado L; San-José ME; Rodríguez-Berrocal FJ; Fernández-Villar A
    Sci Rep; 2020 Mar; 10(1):5679. PubMed ID: 32231227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid calprotectin test for the diagnosis of pleural effusion.
    Casado-Rey P; Vázquez-Iglesias L; Botana-Rial M; Andrade-Olivié MA; Ferreiro-Fernández L; San José Capilla E; Nuñez-Ares A; Bollo de Miguel E; Pajares-Ruíz V; Fernández-Villar A
    PLoS One; 2021; 16(6):e0252714. PubMed ID: 34111153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion.
    Fiorelli A; Morgillo F; Fasano M; Vicidomini G; Di Crescenzo VG; Di Domenico M; Accardo M; Santini M
    Interact Cardiovasc Thorac Surg; 2013 Mar; 16(3):263-9. PubMed ID: 23190621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an automated commercial ELISA method for calprotectin determination in pleural fluid.
    Vázquez-Iglesias L; Casado-Rey P; Botana-Rial M; Andrade-Olivié MA; Rodriguez-Berrocal FJ; Páez de la Cadena M; Fernández-Villar A
    Clin Chem Lab Med; 2017 Jul; 55(8):e172-e174. PubMed ID: 27898399
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
    Wei F; Wei Y; Li LF; Li GL; Wang GJ
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
    [No Abstract]   [Full Text] [Related]  

  • 9. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
    Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
    Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of periostin in lung cancer-related malignant pleural effusion.
    Zhang J; Zha T; Zhang N; Sun G
    J Clin Lab Anal; 2022 Feb; 36(2):e24179. PubMed ID: 35152510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
    Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
    Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.
    Fiorelli A; Vicidomini G; Di Domenico M; Napolitano F; Messina G; Morgillo F; Ciardiello F; Santini M
    Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):420-4. PubMed ID: 21172937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of MUC1 and EpCAM mRNA as tumor markers in differentiating benign from malignant pleural effusion.
    Sun W; Li J; Jiang HG; Ge LP; Wang Y
    QJM; 2014 Dec; 107(12):1001-7. PubMed ID: 24939190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
    Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
    Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
    Dong J; Sun G; Zhu H
    Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.
    Pass HI; Levin SM; Harbut MR; Melamed J; Chiriboga L; Donington J; Huflejt M; Carbone M; Chia D; Goodglick L; Goodman GE; Thornquist MD; Liu G; de Perrot M; Tsao MS; Goparaju C
    N Engl J Med; 2012 Oct; 367(15):1417-27. PubMed ID: 23050525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema.
    Wu KA; Wu CC; Liu YC; Hsueh PC; Chin CY; Wang CL; Chu CM; Shih LJ; Yang CY
    BMC Pulm Med; 2019 Jun; 19(1):108. PubMed ID: 31215423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions.
    Korczynski P; Krenke R; Safianowska A; Gorska K; Abou Chaz MB; Maskey-Warzechowska M; Kondracka A; Nasilowski J; Chazan R
    Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):128-33. PubMed ID: 20156743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in diagnosis of pleural effusion of malignant origin.
    Fiorelli A; Ricci S; Feola A; Mazzella A; D'Angelo L; Santini M; Di Domenico M; Di Carlo A
    Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):411-8. PubMed ID: 26769731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.
    Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
    Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.